Trending

Mankind Pharma shares in focus as company approves Rs 10,000 crore fundraise plan

Image

The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months, in a regulatory filing to stock exchanges.

You Might Also Like...

Sign Up for Our Newsletter

Subscribe now to get notified about exclusive offers
from The .... every week!